Sunday, 17 February

08:00 – 09:30 Davos 2

Session 1: Risk Factors, Lifestyle Modification

Chairs:
F. Mach, Geneva
P. Libby, Boston

08:00 – 08:20

Lifestyle modification in CV prevention

M. F. Piepoli, Piacenza
08:20 – 08:40

How can exercise training influence risk management?

S. Sharma, London
08:40 – 09:00

Salt, blood pressure and risk: the PURE study

S. Yusuf, Hamilton
09:00 – 09:20

What is a healthy diet?

N. Teicholz, New York
09:20 – 09:30

Panel discussion

09:30 – 10:00

Coffee


10:00 – 11:30 Davos 2

Session 2: Lipids and Atherosclerosis

Chairs:
S. Sharma, London
S. Yusuf, Hamilton

10:00 – 10:20

LDL and cardiovascular disease: is there enough evidence?

A. L. Catapano, Milan
10:20 – 10:40

Is plasma LDL-cholesterol necessary? LDL targets of the future

F. Mach, Geneva
10:40 – 11:00

RNA interference to lower lipids and triglycerides

U. Landmesser, Berlin
11:00 – 11:20

Residual risk: CANTOS and beyond

P. Libby, Boston
11:20 – 11:30

Panel discussion

12:00 – 13:15 Seehorn

Satellite Symposium Boehringer Ingelheim (a lunch bag will be offered)

Empagliflozin: From diabetes control to cardiovascular protection

Chairman:
T. F. Lüscher, London, Zurich

12:00 – 12:25

EMPA-REG® OUTCOME: Breakthrough in diabetes care

S. D. Anker, Berlin
12:25 – 12:50

EMPRISE® Program: Real-world evidences on Empagliflozin efficacy, safety and costs

A. Karasik, Ramat Gan
12:50 – 13:15

Panel discussion

13:30 – 15:00 Davos 2

Session 3: Diabetes and the Heart

Chairs:
M. F. Piepoli, Piacenza
F. Paneni, Zurich
P.-M. Schumm-Dräger, Munich

13:30 – 13:50

Diabetes and cardiovascular outcome

J. E. Deanfield, London
13:50 – 14:10

Diabetic cardiomyopathy: are the expectations higher than proofs?

P. M. Seferovic, Belgrade
14:10 – 14:30

New trials in HF and diabetes

M. Packer, Dallas
14:30 – 14:50

Diabetes Guidelines: new evidence and future changes

F. Cosentino, Stockholm
14:50 – 15:00

Panel discussion

15:00 – 15:30

Coffee


15:00 – 16:30 Foyer

Poster Session: Atherosclerosis, Risk Factors, Basic Science

Chairs:
P. Libby, Boston
G. G. Camici, Zurich

15:30 – 16:30 Schwarzhorn

Meet the Expert Session ─ Lifestyle / Diet

Panel and speakers:
S. Yusuf, Hamilton
J. Scholl, Rüdesheim am Rhein
N. Teicholz, New York

15:30 – 16:30 Seehorn

Meet the Expert Session ─ Lipid Management

Panel and Case Presenters:
F. Mach, Geneva
U. Landmesser, Berlin
A. L. Catapano, Milan
J. H. Beer, Baden
M. Nägele, Zurich

15:30 – 16:30 Wisshorn

Meet the Expert Session ─ Diabetes

Panel and Case Presenters:
M. Packer, Dallas
J. E. Deanfield, London
F. Paneni, Zurich
R. Lehmann, Zurich
P.-M. Schumm-Dräger, Munich


 


16:30 – 17:45 Davos 2

Session 4: Cardio-Oncology

Chair:
J. E. Deanfield, London
A. Lyon, London

16:30 – 16:50

Cardiotoxicity of chemotherapy: which drugs affect the heart?

A. Lyon, London
16:50 – 17:10

Genetic testing for cardiotoxicity of chemotherapeutic agents?

T. Suter, Berne
17:10 – 17:30

Cardiac amyloidosis in view of ATTR-ACT trial

A. V. Kristen, Heidelberg
17:30 – 17:45

Panel discussion

16:30 – 17:45 Davos 1

Session 5: Cardiac Imaging

Chairs:
O. Gämperli, Zurich
S. Windecker, Berne

16:30 – 16:45

The role of coronary CT (anatomic) vs functional testing in the non-invasive assessement of CAD

J. J. Bax, Leiden
16:45 – 17:00

Intravascular imaging: What do we learn from IVUS and OCT?

L. Räber, Berne
17:00 – 17:15

Cardiac CT and nuclear imaging

C. Gräni, Zurich
17:15 – 17:35

Evaluation of left ventricular diastolic function by echocardiography

O. A. Smiseth, Oslo
17:35 – 17:45

Panel discussion

17:30 – 19:15

Dinner Buffet


18:00 – 19:15 Davos 2

Satellite Symposium Sanofi

ODYSSEY: Safe arrival of the flagship for PCSK9 Inhibition

Chairs:
S. Windecker, Berne
F. Mach, Geneva

18:00 – 18:20

Are we all hyperlipidemic? Lessons from evolution

T. F. Lüscher, London, Zurich
18:20 – 18:40

ODYSSEY OUTCOMES: What does a cardiologist need to know

P. G. Steg, Paris
18:40 – 19:00

Risk stratification in secondary prevention: Identification of the right patients for PCSK9 Inhibition

B. Ference, Cambridge
19:00 – 19:15

Panel discussion

19:15 – 20:15 Schwarzhorn

Clinical Decision Seminar ─ Patients with ICD and CRT: troubleshooting

Moderators and Case Presenters:
G. Hindricks, Leipzig
C. Sticherling, Basel

19:15 – 20:15 Seehorn

Clinical Decision Seminar ─ Aortic Valve Disease

TAVI Live in-a-box from Charité Berlin

Moderators and Case Presenters:
R. Binder, Wels
D. M. Leistner, Berlin
J. J. Bax, Leiden
U. Landmesser, Berlin